Aequitas Research

Hong Jie Seow

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

Independent Insight Provider

IPOs and Placements coverage across Asia Pacific

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

Capillary Technologies India Ltd (CTIL) / Equity Capital Markets

Capillary Technologies India Ltd (CTIL) (0611334D IN)

<ul>
<li>
<a href="https://www.smartkarma.com/entities/capillary-technologies-india-ltd-ctil" target="_blank" data-smartkarma-citation="entities:45404:1" rel="noopener">Capillary Technologies India Ltd (CTIL) (0611334D IN)</a> is looking to raise about US$240m in its upcoming India IPO.</li>
<li>Capillary has been able to diversify the uses of its offerings across different industries. Despite declines in number of customers and brands, they have been offset by increased monetization abilities</li>
<li>In this note, we look at the company’s past performance.</li>
</ul>



Capillary Technologies India Ltd (CTIL) (0611334D IN) is looking to raise about US$240m in its upcoming India IPO.
Capillary has been able to diversify the uses of its offerings across different industries. Despite declines in number of customers and brands, they have been offset by increased monetization abilities
In this note, we look at the company’s past performance.


Capillary Technologies India Pre-IPO: Increased Monetization But CFO Turned Negative